Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136493) titled 'Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer' on Aug. 10.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Screening. Masking: None (Open Label).
Primary Sponsor: City of Hope Medical Center
Condition:
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Estrogen Receptor-Positive Breast Carcinoma
HER2-Negative Breast Carcinoma
HER2-Positive Breast Carcinoma
Triple-Negative Breast Carcinoma
Intervention:
Pro...